Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yong-Bock Choi"'
Autor:
Han-Seong Kim, Jae-Soo Koh, Yong-Bock Choi, Jungsil Ro, Hyun-Kyoung Kim, Mi-Kyung Kim, Byung-Ho Nam, Kyung-Tae Kim, Vishal Chandra, Hye-Sil Seol, Woo-Chul Noh, Eun-Kyu Kim, Joobae Park, Chang-Dae Bae, Kyeong-Man Hong
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98160 (2014)
BACKGROUND: The level of proliferation activity is a strong prognostic or predictive indicator in breast cancer, but its optimal measurement is still in debate, necessitating new proliferation markers. In the present study, the prognostic significanc
Externí odkaz:
https://doaj.org/article/ffcfe40a5d494da9aca625e9dbaff19c
Autor:
Jun Huan Kim, June Hyun Kim, Yong Hee Kim, Young-Sun Sohn, Jung Min Sim, Yong Bock Choi, Ha Jung Lee
Publikováno v:
Korean Journal of Plant Resources. 29:588-597
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12087d47cbde57feda497ee5890407b3
https://doi.org/10.7732/kjpr.2016.29.5.588
https://doi.org/10.7732/kjpr.2016.29.5.588
Autor:
Vishal, Chandra, Yong-Bock, Choi, Hai-Li, Hwang, Jeong-Hwa, Lee, Seong-Yeol, Park, Hyun-Kyoung, Kim, Shiv, Poojan, Jae-Soo, Koh, Han-Seong, Kim, Kyeong-Man, Hong
Publikováno v:
Histology and histopathology. 30(9)
We have shown both LLC1 expression in the lung epithelium by in situ hybridization and its inactivation in lung cancer by epigenetic modification. However, LLC1 protein's cellular localization or its role in normal lung or cancer tissues has not yet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d61e5752ad42218054d1989b648372a8
https://pubmed.ncbi.nlm.nih.gov/25786037
https://pubmed.ncbi.nlm.nih.gov/25786037
Autor:
Moon-Kee Paik, Yong-Bock Choi, Kyeong-Man Hong, Dong-Eun Park, Chang-Ho Shin, Kyung Suk Kim, Myoung-Hyun Ko
Publikováno v:
Experimental & Molecular Medicine. 37:155-160
The methylation of a 23-kDa nuclear protein increased after partial hepatectomy and methylation returned to basal levels after the initial stage of regeneration. The methylating enzyme was partially purified from rat liver by ammonium sulfate precipi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2c597b2a3fabaae7793e1eabe5bfd4
https://doi.org/10.1038/emm.2005.21
https://doi.org/10.1038/emm.2005.21
Autor:
Jae-Soo Koh, Yong-Bock Choi, Hyun-Kyoung Kim, Jungsil Ro, Eun Kyu Kim, Joobae Park, Woo-Chul Noh, Kyung-Tae Kim, Byung-Ho Nam, Mi-Kyung Kim, Hanseong Kim, Hyesil Seol, Kyeong-Man Hong, Vishal Chandra, Chang-Dae Bae
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98160 (2014)
PLoS ONE
PLoS ONE
BACKGROUND: The level of proliferation activity is a strong prognostic or predictive indicator in breast cancer, but its optimal measurement is still in debate, necessitating new proliferation markers. In the present study, the prognostic significanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9978097f52b54583a54fb19c79710080
http://europepmc.org/articles/PMC4041571?pdf=render
http://europepmc.org/articles/PMC4041571?pdf=render
Autor:
Seong Won Song, Eui Jung Jung, Song Jae Lee, Chang Young Kim, Sung Won Min, Jong Won Oh, Yong Bock Choi, Jae Kyung Song
Publikováno v:
Journal of microbiology and biotechnology. 23(9)
The humanized anti-hepatocyte growth factor (HGF) monoclonal antibody (mAb) YYB-101 is a promising therapeutic candidate for treating various cancers. In this study, we developed a bioprocess for large-scale production of YYB-101 and evaluated its th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464f16fb780ba65b47843448f6d5103e
https://pubmed.ncbi.nlm.nih.gov/23851271
https://pubmed.ncbi.nlm.nih.gov/23851271
Autor:
Kyeong Man Hong, Kang Seo Park, Jae Heon Jeong, Dae Seok Kim, Hyeong Ryul Kim, Seong Yeol Park, Yong Bock Choi, Hyun Kyoung Kim, Chang-Min Choi, Byung-Ho Nam, Soo Youl Kim, Se Jin Jang
Publikováno v:
Molecular Cancer, Vol 10, Iss 1, p 119 (2011)
Molecular Cancer
Molecular Cancer
Background Expression of transglutaminase 2 (TGase 2) is related to invasion and resistance to chemotherapeutic agents in several cancer cells. However, there has been only limited clinical validation of TGase 2 as an independent prognostic marker in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b77b5f768107e6342acf2cbf139b39
http://www.molecular-cancer.com/content/10/1/119
http://www.molecular-cancer.com/content/10/1/119
Autor:
Kyung Ah Cho, Ju Young Seoh, Seong-Yeol Park, So Youn Woo, Yun-Jae Jung, Kyung Ha Ryu, Kyung‑man Hong∥, Sun Young Joo, Han Seong Kim, Yong‑Bock Choi∥
Publikováno v:
Cell biology international. 35(4)
Cell therapy using MSCs (mesenchymal stem cells) might be effective treatment for refractory GVHD (graft-versus-host disease). However, the fate and distribution of MSCs after transplantation remains unclear. In this study, an animal model was develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33cdcaabeeec3d05682a74b39375c2c8
https://pubmed.ncbi.nlm.nih.gov/21062262
https://pubmed.ncbi.nlm.nih.gov/21062262
Autor:
Kyeong-Man Hong, Su Jin Cho, Kyung-Ah Cho, Yun-Jae Jung, Kyung Ha Ryu, Hanseong Kim, Seong-Yeol Park, Ju Young Seoh, Yong-Bock Choi, Sun-Young Joo, So Youn Woo
Publikováno v:
Cytotherapy. 12(3)
Graft-versus-host disease (GvHD) remains a major complication after allogeneic hematopoietic cell transplantation (HCT). Recent literature demonstrates a potential benefit of human mesenchymal stromal cells (MSC) for the treatment of refractory GvHD;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d379294dfd67bcf744ad8839f40905
https://pubmed.ncbi.nlm.nih.gov/20078382
https://pubmed.ncbi.nlm.nih.gov/20078382
Autor:
Kang-Seo Park, Kyeong-Man Hong, Jung-Hwa Lee, Sei-Hoon Yang, Hyun-Kyoung Kim, Soo-Youl Kim, Yong-Bock Choi, Seong-Yeol Park
Publikováno v:
Journal of cancer research and clinical oncology. 136(4)
Recently, it was reported that expression of transglutaminase 2 plays an important role in doxorubicin/cisplatin resistance in breast and ovarian cancer. The aims of this study were to verify the role of transglutaminase 2 in cisplatin response in no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41079cd4c889fcb8b7d6bfa5aa236bc6
https://pubmed.ncbi.nlm.nih.gov/19763620
https://pubmed.ncbi.nlm.nih.gov/19763620